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Background
The ability to screen for asymptomatic malaria infection
at a field level is increasingly recognized as a key strategy
in malaria elimination campaigns. However, molecular
methods necessary to detect very low parasite density
infections, such as PCR, are restricted to reference-level
laboratories and require considerable training to perform.
To be effective, such techniques must be close enough to
the positive cases to enable rapid treatment. Loop-
mediated isothermal DNA amplification (LAMP) is
highly sensitive and specific, faster than PCR, requires
minimal processing and instrumentation, and allows
result detection with the naked eye.
Materials and methods
FIND has been working with the Hospital for Tropical
Diseases in London and Eiken Chemical Company (Japan)
in the development of a simplified LAMP assay for the
diagnosis of malaria. An optimized test targeting different
sequences in the mitochondrial DNA was developed for
the detection of parasitaemias below 1 parasite/µl of blood
in less than 40 minutes. Prototypes of this test have been
compared to PCR with samples from febrile patients in
two clinical trials, one in London (travelers) and other in
an endemic setting in Uganda.
Results
Both clinical trials have demonstrated that LAMP is
equivalent to nested PCR in sensitivity and specificity with
faster time-to-results. In London with 705 samples, sensi-
tivity and specificity of the LAMP P. falciparum primers
were 98.4% and 98.1% respectively, and for the LAMP Pan
primers, 97.0% and 99.2% respectively. In Uganda, 272
samples were tested with the LAMP P. falciparum primers
and sensitivity and specificity were 93.3% and 85% respec-
tively. This performance of the LAMP assay for malaria
was achieved using two simple DNA extraction methods
that take only 15 minutes per sample. The study in
Uganda also demonstrated that technicians without mole-
cular training could perform the test after a short training
period in a simple laboratory space with basic equipment.
Conclusions
This LAMP test has potential applications both as refer-
ence standard for other diagnostics, for primary diagnosis
of returned travelers in non-endemic countries, , and as a
tool for population screening in malaria elimination cam-
paigns. A high-throughput assay suited to large-scale
screening studies is on development.
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